Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Research Article
  • Published:

Intravenous injection of oligodeoxynucleotides to the NF-kappaB binding site inhibits hepatic metastasis of M5076 reticulosarcoma in mice

Gene Therapy volume 8, pages 905–912 (2001)Cite this article

Abstract

We have developed synthetic double-stranded oligodeoxynucleotides (ODN) as ‘decoy’ cis elements that block the binding of nuclear factors to promoter regions of targeted genes, resulting in the inhibition of gene transactivation in vivo. In the present study, we employed decoy ODN targeting the transcription factor nuclear factor-kappaB (NF-kappaB) binding cis-elements to hepatic metastasis of murine reticulosarcoma M5076 in mice. Intravenous inoculation of M5076 into mice caused a marked increase in gene expression of interleukin-1β, tumor necrosis factor-α and intercellular adhesion molecule-1 in the liver, whereas intravenous treatment with NF-kappaB decoy ODN reduced M5076-induced transactivation of these genes. Treatment with NF-kappaB decoy ODN, but not scrambled decoy ODN, significantly inhibited hepatic metastasis of M5076 in mice, and furthermore the combined treatment of NF-kappaB decoy ODN with an anti-cancer drug resulted in complete inhibition of hepatic metastasis in half of the mice, without affecting myelosuppression induced by the anti-cancer drug. Here, NF-kappaB decoy ODN inhibited hepatic metastasis of M5076 in mice possibly through a decrease in transactivation of important NF-kappaB-driven genes and also potentiated the anti-metastatic effect of an anti-cancer drug, demonstrating the first successful in vivo therapy for cancer metastasis using NF-kappaB decoy ODN as a novel molecular decoy approach.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  1. Fidler IJ . Critical factors in the biology of human cancer metastasis: Twenty-eighth G.H.A. Clowes Memorial Award Lecture Cancer Res 1990 50: 6130–6138

    CAS  Google Scholar 

  2. Talmadge JE . The selective nature of metastasis Cancer Metast Rev 1983 2: 25–40

    Article  CAS  Google Scholar 

  3. Weiss L, Ward PM . Cell detachment and metastasis Cancer Metast Rev 1983 2: 111–127

    Article  CAS  Google Scholar 

  4. Liotta LA . Tumor invasion and metastasis. Role of the extracellular matrix: Rhoads Memorial Award Lecture Cancer Res 1986 46: 1–7

    Article  CAS  Google Scholar 

  5. Nicolson GL . Cancer metastasis: organ colonization and the cell-surface properties of malignant cells Biochim Biophys Acta 1982 695: 113–176

    CAS  PubMed  Google Scholar 

  6. Weiss L, Orr FW, Honn KV . Interactions of cancer cells with the microvasculature during metastasis FASEB J 1988 2: 12–21

    Article  CAS  Google Scholar 

  7. Rice GE, Bevilacqua MP . An inducible endothelial cell surface glycoprotein mediates melanoma adhesion Science 1989 246: 1303–1306

    Article  CAS  Google Scholar 

  8. Albelda SM . Role of integrins and other cell adhesion molecules in tumor progression and metastasis Lab Invest 1993 68: 4–17

    CAS  Google Scholar 

  9. Okahara H, Yagita H, Miyake K, Okumura K . Involvement of very late activation antigen 4 (VLA-4) and vascular cell adhesion molecule 1 (VCAM-1) in tumor necrosis factor α enhancement of experimental metastasis Cancer Res 1994 54: 3233–3236

    CAS  PubMed  Google Scholar 

  10. Glinsky GV . Anti-adhesion cancer therapy Cancer Metast Rev 1998 17: 177–185

    Article  CAS  Google Scholar 

  11. Bani MR, Garofalo A, Scanziani E, Giavazzi R . Effect of interleukin-1-beta on metastasis formation in different tumor systems J Natl Cancer Inst 1991 83: 119–123

    Article  CAS  Google Scholar 

  12. Butcher EC . Warner-Lambert/Parke-Davis Award lecture. Cellular and molecular mechanisms that direct leukocyte traffic Am J Pathol 1990 136: 3–11

    CAS  PubMed  PubMed Central  Google Scholar 

  13. Cotran RS . American Association of Pathologists president's address. New roles for the endothelium in inflammation and immunity Am J Pathol 1987 129: 407–413

    CAS  PubMed  PubMed Central  Google Scholar 

  14. Stoolman LM . Adhesion molecules controlling lymphocyte migration Cell 1989 56: 907–910

    Article  CAS  Google Scholar 

  15. Lenardo MJ, Baltimore D . NF-kappa B: a pleiotropic mediator of inducible and tissue-specific gene control Cell 1989 58: 227–229

    Article  CAS  Google Scholar 

  16. Neish AS et al. Functional analysis of the human vascular cell adhesion molecule 1 promoter J Exp Med 1992 176: 1583–1593

    Article  CAS  Google Scholar 

  17. Brennan DC, Jevnika AM, Takei F, Reubin-Kelley VE . Mesangial cell accessory functions: mediation by intercellular adhesion molecule-1 Kidney Int 1990 38: 1039–1046

    Article  CAS  Google Scholar 

  18. Bielinska A, Shivdasani RA, Zhang LQ, Nabel GJ . Regulation of gene expression with double-stranded phosphorothioate oligonucleotides Science 1990 250: 997–1000

    Article  CAS  Google Scholar 

  19. Morishita R, Higaki J, Tomita N, Ogihara T . Application of transcription factor ‘decoy’ strategy as means of gene therapy and study of gene expression in cardiovascular disease Circ Res 1998 82: 1023–1028

    Article  CAS  Google Scholar 

  20. Yamada T et al. In vivo identification of a negative regulatory element in the mouse renin gene using direct gene transfer J Clin Invest 1995 96: 1230–1237

    Article  CAS  Google Scholar 

  21. Morishita R et al. A gene therapy strategy using a transcription factor decoy of the E2F binding site inhibits smooth muscle proliferation in vivo Proc Natl Acad Sci USA 1995 92: 5855–5859

    Article  CAS  Google Scholar 

  22. Morishita R et al. In vivo transfection of cis element ‘decoy’ against nuclear factor-kB binding site prevents myocardial infarction Nature Med 1997 3: 894–899

    Article  CAS  Google Scholar 

  23. Kawamura I et al. Intratumoral injection of oligonucleotides to the NFkB binding site inhibits cachexia in a mouse tumor model Gene Therapy 1999 6: 91–97

    Article  CAS  Google Scholar 

  24. Talmadge JE, Key ME, Hart IR . Characterization of a murine ovarian reticulum cell sarcoma of histiocytic origin Cancer Res 1981 41: 1271–1280

    CAS  PubMed  Google Scholar 

  25. Hart IR, Talmadge JE, Fidler IJ . Metastatic behavior of a murine reticulum cell sarcoma exhibiting organ-specific growth Cancer Res 1981 41: 1281–1287

    CAS  PubMed  Google Scholar 

  26. Yamaoka M et al. Inhibition of tumor growth and metastasis of rodent tumors by the angiogenesis inhibitor o-(chloroacetyl-carbamoyl)fumagillol (TNP-470; AGM-1470) Cancer Res 1993 53: 4262–4267

    CAS  Google Scholar 

  27. Xie K et al. Direct correlation between expression of endogenous inducible nitric oxide synthase and regression of M5076 reticulum cell sarcoma hepatic metastases in mice treated with liposomes containing lipopeptide CGP 31362 Cancer Res 1995 55: 3123–3131

    CAS  PubMed  Google Scholar 

  28. Higgins KA et al. Antisense inhibition of the p65 subunit of NF-kB blocks tumorigenicity and causes tumor regression Proc Natl Acad Sci USA 1993 90: 9901–9905

    Article  CAS  Google Scholar 

  29. Bours V et al. The NF-kB transcription factor and cancer: high expression of NF-kB- and IkB-related proteins in tumor cell lines Biochem Pharmacol 1994 47: 145–149

    Article  CAS  Google Scholar 

  30. Tozawa K, Sakurada S, Kohri K, Okamoto T . Effects of anti-nuclear factor kB reagents in blocking adhesion of human cancer cells to vascular endothelial cells Cancer Res 1995 55: 4162–4167

    CAS  PubMed  Google Scholar 

  31. La Porta CAM, Comolli R . PKC-dependent modulation of IkBα-NFkB pathway in low metastatic B16F1 murine melanoma cells and in highly metastatic BL6 cells Anticancer Res 1998 18: 2591–2597

    CAS  PubMed  Google Scholar 

  32. Hinz M et al. NF-kB function in growth control: regulation of cyclin D1 expression and G0/G1-to-S-phase transition Mol Cell Biol 1999 19: 2690–2698

    Article  CAS  Google Scholar 

  33. Siebenlist U, Franzoso G, Brown K . Structure, regulation and function of NF-kB Annu Rev Cell Biol 1994 10: 405–455

    Article  CAS  Google Scholar 

  34. Wulczyn FG, Krappmann D, Scheidereit C . The NF-kB/Rel and IkB gene families: mediators of immune response and inflammation J Mol Med 1996 74: 749–769

    Article  CAS  Google Scholar 

  35. Kittelberger R, Davis PF, Stehbens WE . An improved immunofluorescence technique for the histological examination of blood vessel tissue Acta Histochem 1989 86: 137–142

    Article  CAS  Google Scholar 

  36. Morishita R et al. Pharmacokinetics of antisense oligonucleotides (cyclin B1 and cdc 2 kinase) in the vessel wall in vivo: enhanced therapeutic utility for restenosis by HVJ-liposome delivery Gene 1994 149: 13–19

    Article  CAS  Google Scholar 

  37. Aoki M et al. In vivo transfer efficiency of antisense oligonucleotides into the myocardium using HVJ-liposome method Biochem Biophys Res Commun 1997 231: 540–545

    Article  CAS  Google Scholar 

  38. Kaneda Y, Iwai K, Uchida T . Increased expression of DNA cointroduced with nuclear protein in adult rat liver Science 1989 243: 375–378

    Article  CAS  Google Scholar 

  39. Suzuki J et al. Prevention of graft coronary arteriosclerosis by antisense cdk 2 kinase oligonucleotide Nature Med 1997 3: 900–903

    Article  CAS  Google Scholar 

Download references

Author information

Author notes

  1. I Kawamura and S Tsujimoto: The first two authors contributed equally to this work

Authors and Affiliations

  1. Medicinal Biology Research Laboratories, Fujisawa Pharmaceutical Co., Ltd., Osaka, Japan

    I Kawamura, S Tsujimoto, T Manda, M Tomoi & T Goto

  2. Department of Geriatric Medicine, Osaka University Medical School, Japan

    R Morishita, N Tomita & T Ogihara

  3. Division of Gene Therapy Science, Osaka University Medical School, Japan

    R Morishita & Y Kaneda

Authors
  1. I Kawamura
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R Morishita
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S Tsujimoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. T Manda
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. M Tomoi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. N Tomita
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. T Goto
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. T Ogihara
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Y Kaneda
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kawamura, I., Morishita, R., Tsujimoto, S. et al. Intravenous injection of oligodeoxynucleotides to the NF-kappaB binding site inhibits hepatic metastasis of M5076 reticulosarcoma in mice. Gene Ther 8, 905–912 (2001). https://doi.org/10.1038/sj.gt.3301478

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.gt.3301478

Keywords

This article is cited by

Search

Advanced search

Quick links